Medscape3d
Drug-Drug Interactions With Glucagon-like Peptide-1 Receptor Agonists
Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...
Yahoo Finance16d
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast 2023-2033
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast 2023-2033 Research and Markets Wed, Feb 19, 2025, 10:09 AM 3 min read ...
CNET on MSN4h
GLP-1 Meds Like Ozempic: Know Potential Benefits, Risk Factors and Overdose Info
G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...
Neurology Advisor4h
GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk
Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 ...
No link seen between preop GLP-1 receptor agonist use and postop aspiration pneumonia
Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative ...
2 Minute Medicine10d
Glucagon-like peptide-1 receptor agonists associated with lower depression risk in older adults with diabetes
In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk of ...
The Cardiology Advisor2d
Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within 1 Year
Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within 1 year.
Hosted on MSN10d
Study finds GLP-1 receptor agonists target fat over muscle for weight loss
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class ...
Medical Xpress10d
Depression risk lower with GLP-1 receptor agonists versus DPP-4 inhibitors in seniors, study reveals
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
Science Daily11d
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
News Medical10d
Genetic study demonstrates fat-selective weight loss with GLP-1 agonist use
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D ...
Monthly Prescribing Reference17d
Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within One Year
This retrospective cohort study involved 125,474 adults with overweight or obesity who newly initiated treatment with a dual-labeled GLP-1 receptor agonist. HealthDay News — Many patients with ...